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ABSTRACT The association between allelic variants and lumbar disc degenerative disease (DDD) has been investigated
in Europe and Northern Asia. However, this has not been investigated in Southeast Asia. This observational study aims to
compare the distribution of COL9A2 and COL9A3 gene polymorphism among male Chinese Singaporeans with and
without lumbar DDD. COL9A2 gene polymorphism was investigated in p326 (tryptophan 2, Trp2 and glutamine 2, Gln2,
alleles) and p335 (valine 2 or Val2 allele). COL9A3 gene polymorphism was investigated in p17 (glycine 3 or Gly3 allele)
and p103 (tryptophan 3 or Trp3 allele). The Val2 allele was significantly decreased in the group with lumbar DDD (p <
0.05). No significant difference in allelic distributions of Trp2, Gln2 and Gly3 was found. The Trp3 allele was absent from
all the subjects. The presence of at least one Val2 allele appears to have a protective effect against DDD. However, these
should be interpreted with caution, given the limitations. Further investigations are warranted in order to verify such
genetic predisposition prior to the potential development of preventative or therapeutic strategies in the near future.
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INTRODUCTION
Degenerative Disc Disease (DDD) is a com-
mon musculoskeletal condition with strong ge-
netic determinants (Seki et al. 2006). It often lea-
ds to physical impairment, requiring surgery and
it contributes significantly to health costs and
work disability in individuals and as well as the
society (Paassilta et al. 2001; Seki et al. 2006;
Solovieva et al. 2006). The environmental fac-
tors contributing to DDD are generally well kno-
wn while research into genetic contributions is
limited (Frymoyer 1988). In recent years, asso-
ciation between allelic variants in the collagen
IX genes and DDD was reported (Annunen et al.
1999; Paassilta et al. 2001; Solovieva et al. 2002).
Collagen IX is a heterotrimer of three alpha
chains, 1(IX), 2(IX) and 3(IX) encoded by the
genes COL9A1, COL9A2 and COL9A3 respec-
tively (Karppinen et al. 2002; Zhang et al. 2008).
Recent studies have suggested an association
between COL9A2 and COL9A3 gene polymor-
phisms with DDD in the Finnish (Annunen et al.
1999; Paassilta et al. 2001), Greek (Kales et al.
2004), Japanese (Higashino et al. 2007) and
Southern Chinese (Jim et al. 2005) individuals.
However, this has not been investigated in
Southeast Asia, particularly Singapore. Whether
there is a difference between ethnic Chinese from
Hong Kong and Singapore may be questioned
by some and yet a phenotypic difference has been
demonstrated in nasopharyngeal carcinoma
(NPC), in that the incidence of NPC varies greatly
among ethnic groups from Kwantung and Fukien
Provinces in Southern China (Clifford 1970; Ho
1972). Similarly, it is assumed that ethnic Chi-
nese from both Hong Kong and Singapore are
likely to share similar genetic background, yet a
striking difference has been shown in cardio-
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vascular mortality between ethnic Chinese liv-
ing in both cities (Zhang et al. 2008). In view of
these findings, there is still a plausible difference
in genetic background between ethnic Chinese
from both cities.
Worldwide, the high prevalence of symptom-
atic DDD accounts for a major proportion of
musculoskeletal disease burden (Jim et al. 2005).
Clarifying the genetic predisposition to DDD will
improve the understanding of the development
and treatment of this disease. As such, the aim of
this study is to compare the distribution of
COL9A2 and COL9A3 gene polymorphism in
symptomatic male Chinese Singaporeans with
and without lumbar degenerative disc disease
(DDD).
MATERIALS AND METHODS
Consecutive symptomatic male Chinese Sin-
gaporean patients who have had pain over their
low back and/or lower limb with duration of at
least 1 month were recruited from the specialist
outpatient clinic (SOC) within the period Aug
08 – Dec 08. These subjects were excluded if
they were present with pain over low back/lower
limbs secondary to non-degenerative causes, for
example, rheumatoid arthritis, traumatic spon-
dylolisthesis etc. Subjects also completed a phy-
sical activity questionnaire (International Physi-
cal Activity Questionnaire IPAQ) short form
(Criag et al. 2003).
Fifty-four subjects (mean age 28.12 years, SD
12.3, confidence interval [CI] 24.8 to 31.4 years)
consented while 6 subjects declined invitation
to participate in this study. These patients then
underwent MRI examinations, which were car-
ried out at the Department of Diagnostic Radio-
logy using a 1.0 or 1.5 Tesla Magnetic Resonance
scanner (Siemens, Erlangen, Germany). The
scans were scored mainly based on the sagittal
T2-weighted turbo spin echo sequences (TR =
4000 milliseconds, TE = 112 milliseconds, slice
thickness = 4mm), although the rest of the mag-
netic resonance sequences in the routine clinical
study were also referred to during reading.
DDD was diagnosed on the basis of signal
changes in the intervertebral discs of lumbar
spine (Schneiderman et al. 1987). The grade of
disc degeneration was determined based on a
previous study (Jim et al. 2005), in which Grade
0 indicated no signal change, Grade 1 a slight
decrease in signal intensity in the nucleus pul-
posus, Grade 2 a generalized hypointense nuc-
leus and Grade 3 a hypointense nucleus with disc
space narrowing using Schneiderman’s classifi-
cation (Schneiderman et al. 1987). The const-
ruct validity of such classification using MRI
was demonstrated when it was 99% accurate in
predicting normality or abnormality as deter-
mined by discography (Schneiderman et al.
1987). Individuals with five Grade 0 discs or
having one Grade 1 disc of the lumbar spine were
assigned as “Normal” (Jim et al. 2005). These
subjects acted as the control group in this ob-
servational study. The rest with more than one
Grade 1 or greater disc of the lumbar spine we-
re assigned as “DDD”. All the MRI scans were
analyzed by only one experienced radiologist
(L.L.C.) who was blinded to the clinical history
of these subjects.
Three milliliters (ml) of blood were drawn
from each patient and genomic DNA was ex-
tracted from the blood followed by amplifica-
tion using QIAamp® DNA Mini Kit. The iso-
lated DNA samples were then stored at 4 deg-
rees Celsius (oC) until further procedures ana-
lyzed the DNA sequence for COL9A2 genotype
variations. COL9A2 gene polymorphism was
investigated in p326 (tryptophan 2, Trp2 and
glutamine 2, Gln2, alleles) and p335 (valine 2 or
Val2 allele) (Table 1). Polymerase chain reac-
tion primers were designed to amplify exon 19
of the human COL9A2 genes. A GeneAmp PCR
system 9700 was used with the following amp-
lification conditions, that is, an initial denatur-
ation at 95 oC for 3 minutes, 35 cycles of 95 oC
for 30 seconds, 60 oC for 45 seconds, 72 oC for 1
minute, and a final extension at 72 oC for 10 min-
utes. The polymerase chain reaction products
were subjected to conformation via gel electro-
phoresis. Products were then purified using
QIAquick® PCR Purification Kit. Sequence
variations observed as heteroduplexes were ex-
amined using a ABI PRISM 3100 Sequencer and
BigDye Terminator Sequencing Kit (Applied
Biosystems, Foster City, CA).
COL9A3 gene polymorphism was investi-
gated in p17 (glycine 3 or Gly3 allele) and p103
(tryptophan 3 or Trp3 allele) (Table 1). Here, a
probe which contained primers (Taqman®, SNP
Genotyping Assays Pre-Designed, Small-Sca-
le, Applied Biosystems, USA) was used. Allelic
discrimination was then examined using a 7500
Fast Real-Time PCR System (Applied Biosys-
tems, Foster City, CA). TaqMan probe primer
set and Genotyping Master Mix were used for
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Table 1: Analysis of the Collagen IX gene sequence variations
Gene
COL9A2
COL9A3
Nucleotide variation
exon 19, p326, 1 st
codon C > T (Trp2)
exon 19, p326, 2nd
codon G > A (Gln2)
exon 19, p335, 1 st
codon C > G (Val2)
exon 1, p17, 2nd
codon A > G (Gly3)
exon 5, p103, 1 st
codon C > T (Trp3)
Primers 5’-3’
Forward: TGGATCTCAGTTTCCCTACCTG
Reverse: CAAGAGGTGGTGATTGAGCAAGAGC
TaqMan® SNP genotyping assays, Applied Biosys-
tems
assay ID- C_16188902_10
assay ID- C_25600748_20
Product
Size (bp)
246
246
246
245
244
Detection
Method
Sequencing
Sequencing
Sequencing
Allelic dis-
crimination
amplification under standard conditions. Initially,
the pre-PCR conditions read at 60oC for 1 minute,
followed by 95oC for 10 minutes. Subsequently,
there were 40 cycles of 95oC for 15 seconds and
60oC for 1 minute. After amplification, the post-
PCR conditions read at 60oC for 1 minute. These
procedures enabled us to compare the  distribu-
tion of COL9A2 and COL9A3 gene po-
lymorphism in symptomatic male Chinese Sin-
gaporeans with and without clinically diagno-
sed lumbar (DDD).
The study protocol was approved by The In-
stitutional Review Board (IRB) of Singapore
General Hospital.
Data Analysis
Descriptive statistics were calculated for age,
height, weight, amount of time spent on sitting
(mins per wk), IPAQ score and grade of disc
degeneration. Data were checked for normality
and homogeneity of variance and paired t tests
were used. Where data were neither of normal
distribution or homogeneity of variance, non-
parametric equivalents were used (using SPSS
16.0 for Windows, SPSS Inc, Chicago, IL
60606). Frequencies were also determined for
all nominal data. Chi-square statistic was used
where significant difference was required (p set
at 0.05).
RESULTS
Out of the 54 subjects who consented to par-
ticipate in this study, thirty-four subjects were
diagnosed with DDD (mean age 30.74 years, SD
14.1, 95% confidence interval [CI] 25.8 to 35.7
years) and 20 were found to have normal MRI
results (the control group) (mean age 23.35 years,
SD 7.46, 95% confidence interval [CI] 19.9 to
26.8 years) (Table 2). Compared to the control
group, there was significantly greater extent of
disc degeneration over the L4/5 and L5/S1 lev-
els in the DDD group (Table 2).
Table 2: Characteristics of subjects (N = 54)
Characterstics Normal MRI1 MRI1 with DDD2 Sig-
findings findings nificance
(N=20) (N=34) (p)
Age, yrs (SD)      23.35 30.74 0.05
      (7.5) (14.1)
Height, m (SD)        1.72 1.74 0.098
      (0.1)   (5.3)
Weight, kg (SD)      68.05  72.4 0.259
    (12.2) (13.3)
Sit mins per wk 72941.5 73905.93 0.089
(2199.4) (2256.9)
IPAQ3 score  6270.98 5873.9 0.667
(6409.4) (8150.8)
Mean grade of disc degeneration (SD)
- L1/24        0.20 0.12 0.220
      (0.4) (0.4)
- L2/35        0.20 0.24 0.121
      (0.4) (0.7)
- L3/46        0.20 0.44 0.452
      (0.4) (0.9)
- L4/57        0.15 1.74 <0.001
      (0.4) (1.2)
- L5/S18        0.35 1.97 <0.001
      (0.6) (1.2)
1
 MRI: Magnetic Resonance Imaging
2
 DDD: Degenerative Disc Disease
3
 IPAQ: International Physical Activity Questionnaire
4
 L1/2: Level of disc between the first and second lumbar
vertebrae
5
 L2/3: Level of disc between the second and third
lumbar vertebrae
6
 L3/4: Level of disc between the third and fourth lumbar
vertebrae
7
 L4/5: Level of disc between the fourth and fifth lumbar
vertebrae
8
 L5/S1: Level of disc between the fifth lumbar vertebra
and first sacral vertebra
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The Val2 allele was present in both groups
(DDD: 20.6%, control 50.0%, p < 0.05) (Table
3). Distributions of Trp2, Gln2 and Gly3 were
11.8%, 73.5% and 8.82% for DDD respective-
ly and 15.0%, 75.0% and 5.0% for controls re-
spectively. No significant difference in allelic
distributions was found between the two groups
(Table 3). The Trp3 allele was absent from all
the subjects.
DISCUSSION
To date, this is the first paper to report on the
significant difference in the distribution of the
Val2 allele frequency among symptomatic con-
trols (50%) and subjects with DDD (20.6%).
Interestingly, none of the Val2 subjects with DDD
have moderate or severe disc degeneration. Such
Val2 allele frequency was also found in 7% of
Finnish patients with discogenic sciatica, 8% in
healthy controls and as well as 5% of controls
with osteoarthritis (Paassilta et al. 2001). The
mechanism by which Val for Leucine (Leu) sub-
stitution could contribute to DDD remains open
to speculation. Both Val and Leu are hydropho-
Table 3: Distribution of COL9A2 and COL9A3 gene polymorphism
Gene MRI findings χ2 and p
Normal DDD Total
N % N % N % χ2 P
COL9A2 p326 1st codon
(Trp2) (n = 54)
C/C 17 36.2 30 63.8 47 87.0 1.036 0.596
T/T 0 0.0 1 100.0 1 1.9
C/T 3 50.0 3 50.0 6 11.1
COL9A2 p326 2nd codon
(Gln2) (n = 54)
G/G 5 35.7 9 64.3 14 25.9 1.975 0.373
A/A 1 14.3 6 85.7 7 13.0
G/A 14 42.4 19 57.6 33 61.1
COL9A2 p335 1st codon
(Val2) (n = 54)
C/C 10 27.0 27 73.0 37 68.5 8.413 0.015
G/G 0 0.0 2 100.0 2 3.7
C/G 10 66.7 5 33.3 15 27.8
COL9A3 p17 2nd codon
(Gly3) (n = 54)
A/A 19 38.0 31 62.0 50 92.6 0.268 0.604
G/G 0 0.0 0 0.0 0 0.0
A/G 1 25.0 3 75.0 4 7.4
COL9A3 p103 1st codon
(Trp3) (n = 54)*
C/C 20 37.0 34 63.0 54 100.0 - -
T/T 0 0.0 0 0.0 0 0.0
C/T 0 0.0 0 0.0 0 0.0
*Chi-square statistics was not computed since Trp3 allele was absent from all the subjects in this study.
bic and generally buried in folded proteins. It
was reported that matrix acidity in a disc microen-
vironment of Sprague-Dawley rats caused a de-
crease in proliferation and viability of mesen-
chymal stem cells and was associated with a
change in cell morphology (Wuertz et al. 2009).
However, the pH of both Val and Leu are 5.96
and 5.98 respectively. In addition, Leu has an
additional methylene group in its side chain com-
pared with Val. We do not know if such differ-
ence in quarternary structures would alter the
function of collagen IX or interfere with the co-
valent bonds between collagen IX and cartilage
fibrils of collagen II which results in a change in
the mechanical property of the intervertebral disc.
The influence of Val2 allele on DDD merits fur-
ther investigation.
No significant difference in Trp2, Gln2 and
Gly3 allelic distributions was found between the
control and DDD groups in this study. With the
exception of Trp2 allele, Gln2 and Gly3 allelic
distribution were not reported across the litera-
ture. The Trp2 allele was present in three sub-
jects without DDD (out of 20) and four subjects
with DDD (out of 34), all of whom were in the
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age group 18-29 years. This infers a lack of as-
sociation between DDD and Trp2 in the age
group 18-29 years, which is consistent with find-
ing reported by Jim and co-workers (Jim et al.
2005). Trp2 allele was found in 4% of affected
Finnish individuals but none in their asymptom-
atic controls (Annunen et al. 1999). Here, recruit-
ment of subjects was based on patients with
symptoms of sciatica, which may have different
underlying causes (Jim et al. 2005). However,
the Trp2 allele was reported to be absent from
the Greek patients (Kales et al. 2004). The Trp2
allele was also reported to be present in 20% of
the Southern Chinese population (Jim et al.
2005). The presence of Trp2 allele was reported
to be a significant age-dependent risk factor for
DDD as affected Trp2 individuals, especially
those at 40 to 49 years, had a 2.4 fold increase in
the risk of developing DDD (Jim et al. 2005). It
was further suggested that Trp2 mutation in col-
lagen IX could render the intervertebral disc
structurally weaker and therefore more vulner-
able to stress from repeated loading. More re-
cently, Trp2 was reported to be present in 21.4%
of Japanese patients who had low back pain and/
or sciatica (Higashino et al. 2007). Similarly, their
result also suggested that Trp2 allele was an age-
dependent risk factor for DDD particularly in
patients under 40 years old. They reported that
patients under 40 years with the Trp2 allele had
a 6 fold increase in the risk of developing more
severe disc degeneration. It is conceivable that
the Trp2 allele could be expressed differently at
different stages of the life span in an individual,
although further study in this area would be war-
ranted.
Interestingly, the Trp3 allele was similarly
absent in this and other studies involving Asians
(Jim et al. 2005; Higashino et al. 2007). How-
ever, this allele was identified as a common pre-
disposing factor in the Finnish patients (12.2%
of the patients with sciatica and 4.7% of their
asymptomatic controls had this allele) (Paassilta
et al. 2001). The presence of at least one Trp3
allele increased the risk of developing DDD by
about 3 fold. The Trp3 allele was also reported
to be present in 8.6% of the Greek patients with
surgically and radiologically proven herniated
discs and 4.9% of their asymptomatic controls
(Kales et al. 2004). Rather than selection bias,
such difference in allelic frequency could be due
to ethnic differences, implying that the Trp3 al-
lele is not a common risk factor for DDD in the
Southern Chinese population (Jim et al. 2005),
Japanese (Higashino et al. 2007) and possibly
male Chinese Singaporean population.
Several limitations in this study deserve con-
sideration. Firstly, the small sample size in this
study could limit external validity. The baseline
genetic equilibrium based on the Hardy-Wein-
berg equilibrium model could not be achieved
in this pilot study. Secondly, with reference to
the distribution of Val2 allele, it is worthwhile
taking note of the total number of allele “G” in
the control group (n=10) and lumbar DDD gro-
up (n=9) (Table 3). From a statistical point of
view, that is, based on a 2x2 Chi2 test (Yates Chi),
the total number of allele “G” in the control gro-
up is not statistically greater than the lumbar
DDD group (χ2 =1.6614, p= 0.1974). Thirdly,
participants in the control group had significantly
less disc degeneration at the lower lumbar levels
than those in the DDD group, likely to be linked
to the latter being significantly older than the
former (Table 2). We did not statistically adjust
for potentially confounding factors such as age
and level of disc degeneration because of the
small sample size. Fourthly, this pilot case-con-
trol study may not be the most appropriate re-
search design. Although some temporal relation-
ship can be assumed to exist between gene poly-
morphisms and development of symptomatic
DDD, given that expression of some allele, such
as the Trp2 allele, may differ during the lifespan,
a prospective cohort design could be consider-
ed. Lastly, the significant difference between the
control and lumbar DDD group for the distribu-
tion of Val2 allele at 19 p335 of COL9A2 gene
may be due to linkage disequilibrium with other
loci, statistical fluctuation or even type I error.
Therefore, the results from this pilot observa-
tional study require further investigation in or-
der to verify genetic predisposition.
In conclusion, the distribution of Val2 allele
was significantly decreased in subjects with
DDD. The presence of at least one Val2 allele at
exon 19 p335 of COL9A2 gene appears to have
a protective effect against DDD. These findings
should be interpreted with caution, given the li-
mitations. Nevertheless, this study has estab-
lished preliminary evidence of different distri-
butions of Val2 allele in symptomatic male Chi-
nese Singaporeans with and without radiolo-
gically diagnosed DDD.
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Appendix 1: Schneiderman’s classification (Schneiderman et al. 1987)
Definition of MRI signal intensity
Term Definition
Normal Normal height and signal intensity
Intermediate Speckled pattern or heterogenous decreased signal intensity
Marked Diffuse loss of signal
Absent Signal void
Definition of discographic patterns
Term Definition
Normal Normal disc appearance
Herniated Protrusion of contrast beyond the normal disc margin
Degenerated Loss of height, even distribution of contrast throughout the disc rather than centralization
in nucleus, or fissuring
Degenerated herniated Degenerated but with protrusion of contrast beyond normal disc margin
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